Commerzbank Aktiengesellschaft’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Commerzbank Aktiengesellschaft's BMY Position: Q3 2026 in Review
Commerzbank Aktiengesellschaft increased its Bristol-Myers Squibb (BMY) stake by 255% in Q3 2026, buying an estimated $2.98M and bringing the position to 65,604 shares worth $4.09M. The position accounts for 0.08% of the portfolio, ranked #124.
Commerzbank Aktiengesellschaft first reported a position in BMY in Q2 2013 and has held it in 39 quarters since. The position peaked at $48.6M in Q4 2019. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Commerzbank Aktiengesellschaft held 65,604 shares of Bristol-Myers Squibb worth $4.09M as of Q3 2026.
- Commerzbank Aktiengesellschaft bought 47,109 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.98M.
- Bristol-Myers Squibb made up 0.08% of Commerzbank Aktiengesellschaft's portfolio in Q3 2026, its #124 holding.
- Commerzbank Aktiengesellschaft first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 39 quarters since.
- Commerzbank Aktiengesellschaft's Bristol-Myers Squibb position peaked at $48.6M in Q4 2019.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2026, filed 10 Nov 2026.